Dr Patrizia Cavazzoni

news

FDA proposes four APIs for bulk substances list for outsourcing facilities

Four APIs are being considered by the FDA for its…

31 July 2020 | By Victoria Rees (European Pharmaceutical Review)

Four APIs are being considered by the FDA for its bulk drug substances list for potential use by outsourcing facilities when compounding if there is a clinical need.

news

FDA revokes emergency use authorisation for chloroquine and hydroxychloroquine as COVID-19 treatments

Following ongoing analysis and emerging scientific data, the FDA has…

16 June 2020 | By Victoria Rees (European Pharmaceutical Review)

Following ongoing analysis and emerging scientific data, the FDA has taken away its emergency use authorisation for chloroquine and hydroxychloroquine, finding they are unlikely to be effective as COVID-19 treatments.